Navigation Links
MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE,Molecule

sed on the areas of infectious disease, cancer and inflammatory diseases. With more than 2,500 employees worldwide, MedImmune is headquartered in Maryland. For more information, visit the company's website at www.medimmune.com.

About Micromet, Inc. (www.micromet-inc.com)

Micromet, Inc. is a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases. Two product candidates are currently in clinical trials. MT103/MEDI-538, which is the first product candidate based on Micromet's proprietary BiTE(R) product development platform, is being evaluated in a phase 1 clinical trial for the treatment of patients with non-Hodgkins lymphoma. The BiTE product development platform is based on a unique, antibody-based format that leverages the cytotoxic potential of T cells, the most powerful 'killer cells' of the human immune system. Adecatumumab (MT201), a recombinant human monoclonal antibody which targets EpCAM expressing tumors, has completed two phase 2a clinical trials, one in patients with breast cancer and the other in patients with prostate cancer. In addition, a phase 1b trial evaluating the safety and tolerability of MT201 in combination with docetaxel is currently ongoing in patients with metastatic breast cancer. Micromet has established collaborations with MedImmune, Inc. for MT103/MEDI-538 and Merck Serono for adecatumumab (MT201).

Forward-Looking Statements of MedImmune, Inc.

This announcement contains, in addition to historical information, certain "forward-looking statements" regarding the development of a novel BiTE(R) molecule (bscEphA2xCD3) targeting the tyrosine kinase receptor EphA2 to treat certain cancers. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
4. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
5. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
6. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
7. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
8. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
9. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
10. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference
11. Publication Confirms that EpCAM, the Target for Two of Micromets Product Candidates, Is Overexpressed on Cancer Stem Cells of Certain Cancers
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: MedImmune and Micromet Publish Data Novel Anti Cancer BiTE Molecule
(Date:7/24/2008)...uscle and Blood Vessel Formation in ... 24 /- Results of a,preclin...dified to express,stromal derived factor-1(alpha) ...dium of rats, which suggest improved heart functio...ngs -- the International Society for,Magnetic Reso...
(Date:7/24/2008)...eeds Oncology Patient Accrual, DENVER, July 24 /P...ent,Organization (RMO), has contracted with five l...h and site management services for their,clinical ...ategy. The new,trials include the following diseas...Metastatic Breast Cancer, Metastatic Sarcoma, Chro...
(Date:7/23/2008)...ic Therapy to Treat the Disease -, WAYNE, N.J. an...l/ --,Bayer HealthCare Pharmaceuticals and Onyx Ph... that The New England Journal of Medicine publishe...xavar(R) (sorafenib),tablets decreased the absolut...esectable hepatocellular carcinoma (HCC), or liver...
(Date:7/23/2008)...uoroPharma Inc., a company developing,breakthrough...n Tomography,(PET) market, announced positive Phas...ed tracer for myocardial perfusion imaging. BFPET ... complete Phase I clinical,development., BFPET is... flow in the,heart (myocardial perfusion). Myocard...
Breaking Medicine Technology:Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 2Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 3Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 4Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 5Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study 6Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 2The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 3The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 4The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 5The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer 6FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 2FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET) 3ThermoGenesis Announces Receipt of CE Mark for MarrowXpress 28TM 29 6108 1ThermoGenesis Announces Receipt of CE Mark for MarrowXpress 28TM 29 6108 2ThermoGenesis Announces Receipt of CE Mark for MarrowXpress 28TM 29 6108 3Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China 6105 1Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China 6105 2Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China 6105 3Beike Biotech Opens Comprehensive Stem Cell Storage and Processing Facility in China 6105 4Scientists may have solved an ecological riddle 3701 1Scientists may have solved an ecological riddle 3701 2Perspective 3A Policies must keep pace with genetic progress 3698 1Perspective 3A Policies must keep pace with genetic progress 3698 2
(Date:7/25/2008)...ne is supporting the US Department of Defense and ...olden Phoenix. Operation Golden Phoenix is a, fo...designed to assist, federal, state and local agenc...enarios. Dataline is providing a vital, ad-hoc, se...dical use during the exercise., NORFOLK, Va., Jul...
(Date:7/25/2008)...HAUMBURG, Ill., July 25 /PRNewswire/ -- Sagent Pha...rmaceutical company, today announced that it,has l... antiarrhythmic,indicated for the treatment and pr...illation and hemodynamically unstable ventricular,...gular heart beat.,Sagent,s amiodarone HCl injectio...
(Date:7/25/2008)...finds fluid back-up in esophagus can cause immune ...thDay News) -- The first evidence linking gastroes... discovered by Duke University Medical Center rese...tions was first noted in the 1970s, and since then... percent of asthma patients also experience GERD s...
(Date:7/25/2008)... Whether you are an Olympian, P...ior, there are Five Things You Need to Know about ...I.S.C. Spine and Sports Center , ...08 -- America,s premier athletes are heading to Be...oning and sacrifice in the hopes of capturing an O...
Breaking Medicine News(10 mins):Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5
...new test may be an important tool in the fight aga...ical Electroencephalography highlights the use of ...lier, which may lead to improved treatment. The te... detects impaired memory, which is known to preced...
...ile health experts tirelessly warn that the long-t...kin cancer, the short-term effects can be blazingl... beach. Characterized by bright, red skin that is ...unburn is a sure, almost immediate sign that you d...
...alian researchers claim eating pizza regularly red...rcent. The risk of developing colon cancer also fe...hey claimed. The researchers polled 3,300 people w...phagus, throat or colon and 5,000 people who had n...
...mmon painkillers may lower the risk of developing ... the greater the benefit, scientists said on Frida...ct of painkillers, known as non-steroidal anti-inf...ke them are less likely to develop the illness, wh...
Other Medicine News:
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: